Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)
Protocol ID
ARST2031
Disease (Sub Disease)
Rhabdomyosarcoma
Diagnosis Stage
Newly diagnosed
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Trial Status
Preparing to Open
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 50 Years
International registry ID's
NCT04994132
Back to Registry
Study Title A Randomized Phase 3 Trial of Vinorelbine Dactinomycin and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine Dactinomycin and Cyclophosphamide (VAC) plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)
Protocol ID ARST2031
Disease (Sub Disease) Rhabdomyosarcoma
Diagnosis Stage Newly diagnosed
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT04994132
Trial Status Preparing to Open
Study Type Treatment
Phase Phase 3
Age Eligibility up to 50 Years
International registry ID's NCT04994132